Fig 1: The expression of Fascin actin-bundling protein 1 (FSCN1) in tongue squamous cell carcinoma (TSCC)a Comparison of all of the genes over-expressed in tongue squamous cell carcinoma vs. normal tissues in the Estilo study. b Relative FSCN1 expression in tongue squamous cell carcinoma vs. normal tissues in the Talbot, Estilo, Ye, and Kuriakose databases. FSCN1 is overexpressed in human TSCC tissues (T) compared to the adjacent normal tissues (N) in TSCC microarray data sets available from Oncomine. c Immunoblotting analysis of FSCN1 protein levels in five TSCC cell lines and normal tongue tissue. d Immunoblotting evaluates the knockdown efficiency of FSCN1 with two unique shRNAs (#1, #2) in CAL-27 and SCC-25 cells. Normal: normal tongue tissue; Scramble (sc): the lentiviral vector with a scrambled sequence that does not target any mRNA. ß-Actin was included as a loading control. All statistical analyses were performed using Student paired t test. All statistical tests were two-sided. Data is presented as mean ± S.D. **p < 0.01 vs. the corresponding control groups
Fig 2: Fascin-1 is prominently expressed and accumulates outside the lesion core after SCI. (A) Western blot analysis shows significant upregulation of Fascin-1 at 7 and 14 days after injury compared to the control (pre-operation, Pre). (B) Quantitative analysis of Fascin-1 expression in (A). The blots (n = 5 per group) were quantified by a densitometric method using ImageJ software. GAPDH was used as the loading control. The results are expressed as the mean ± SEM. ***p < 0.001 (14 days vs Pre); * p < 0.05 (7 days vs Pre); ##p < 0.01 (14 vs 3 days). (C) Double immunofluorescence labeling of spinal cord sagittal sections showing the spatiotemporal distribution of Fascin-1 (Red) and GFAP (Green) at Pre and 3, 7, and 14 days after injury. The asterisks indicate the lesion epicenter. Scale bar: 500 µm.
Fig 3: Snail mediates Rab25-induced fascin expression. (a) Cells were co-transfected with indicated vectors and siRNAs. Quantitative RT-PCR for fascin mRNA expression (mean±s.d. **P<0.01 versus control vector with scrambled siRNA, ###P<0.001 versus Rab25 overexpression with scrambled siRNA). (b) MCF-7 cells were co-transfected with indicated vectors and siRNAs. Immunoblotting. (c, d) Cells were co-transfected with indicated vectors and siRNAs (c), or stimulated with VEGF165aa (d). Immunofluorescence with an anti-fascin antibody. Original magnification, × 200; scale bar, 20 µm. (e) SKOV-3 cells were stimulated with VEGF165aa. ChIP analysis. (f) Correlation between FSCN1 gene expression and overall survival in breast (BC), ovarian (OC) and gastric (GC) cancer patients, P=0.01. The K–M plot was drawn in ‘kmplot.com’. (g) Correlation between FSCN1 and SANI1 gene expression in breast, ovarian and gastric cancer patients.
Fig 4: FSCN1 downregulates PTK6 expression in ESCC cell lines. (A–D) Lentivirus containing FSCN1 shRNA sequence (FSCN1-KD) and over-expressed sequence (FSCN1-OE) were added into ECA-109 and KYSE-150 mediums separately. Lentivirus expressing GFP only was used as a negative control (NC). The mRNA (A) and protein level (B–D) of FSCN1 in the 2 cell lines were detected. n = 3 per group, **p < 0.01, ***p < 0.001. (E–H) ECA-109 and KYSE-150 infected by NC, FSCN1-KD, and FSCN1-OE as indicated were harvested, and the mRNA (E) and protein level (F–H) of PTK6 in the 2 cell lines were detected. n = 3 per group, *p < 0.05, **p < 0.01, ***p < 0.001.
Fig 5: TAZ can promote the migration and accumulation of microglia around the lession core to form microglial scar after SCI and Fascin-1-TAZ pathway axis for positively regulating the migration of microglia. In this model, TAZ was downstream of Fascin-1 for regulating microglial migration. TAZ promoted the migration of microglia by Fascin-1 inducing TAZ nuclear accumulation of microglia, which contributed to the migration and accumulation of microglia around the lesion border to form microglial scars and promote functional recovery after SCI.
Supplier Page from Abcam for Anti-Fascin antibody [EP5902]